EMAIL TO A FRIEND COMMENT

 

Molecular Technologies Help Detect and Interrupt Superbug CRE Transmission


On September 2, 2016, the CDC published a report on the use of molecular technologies to detect and interrupt Carbapenem-resistant Enterobacteriaceae (CRE) transmission. CRE are multidrug-resistant gram-negative bacilli that can cause infections associated with high case fatality rates, and are emerging as epidemiologically important health care–associated pathogens in the United States. Prevention of CRE transmission in health care settings is dependent on recognition of cases, isolation of colonized and infected patients, effective use of infection control measures, and the correct use of antibiotics. The use of molecular technologies, including polymerase chain reaction (PCR) testing, pulsed-field gel electrophoresis (PFGE), and whole genome sequencing (WGS), can lead to detection of transmission events and interruption of transmission.

 

In Wisconsin, acute care and critical access hospitals report laboratory-identified CRE to the Wisconsin Division of Public Health (WDPH), and clinical laboratories submit CRE isolates to the Wisconsin State Laboratory of Hygiene (WSLH) for molecular testing. During February–May 2015, a total of 49 CRE isolates from 46 patients were submitted to WSLH. On June 8, WSLH informed WDPH of five carbapenemase-producing CRE isolates with closely related PFGE patterns identified among four inpatients at two hospitals in southeastern Wisconsin. An investigation revealed a high degree of genetic relatedness among the patients’ isolates, but did not identify the mechanism of transmission between the two facilities. No breaches in recommended practices were identified; after reviewing respiratory care procedures, no further cases were identified. Routine hospital- and laboratory-based surveillance can detect and prevent health care transmission of CRE.

 

Since December 1, 2011, WDPH, under its authority in the Department of Health Services Administrative Code Chapter 145, has required all 138 Wisconsin acute care and critical access hospitals to report laboratory-identified CRE, using the multidrug-resistant organism and Clostridium difficile infection module of the National Healthcare Safety Network. The WSLH laboratory-based CRE surveillance program requests all clinical microbiology laboratories to submit carbapenem-nonsusceptible Enterobacteriaceae isolates to WSLH for PCR testing to determine the presence of genes encoding carbapenemase, including KPC, NDM, IMP, VIM, and OXA-48. All CRE isolates determined by PCR testing to have a carbapenemase gene are subtyped by PFGE testing to detect clusters; CRE isolates with PFGE patterns that are indistinguishable or closely related (1–2 band difference) are reported to WDPH’s health care-associated–infection prevention program for epidemiologic follow-up. WSLH’s use of WGS to detect single nucleotide polymorphisms (SNPs) of enteric bacterial pathogens and subsequent expansion of WGS to nonenteric bacteria has further enhanced the capability of WSLH to make genetic comparisons of CRE isolates of interest.

 

During February–May 2015, a total of 49 CRE isolates from 46 patients that met the National Healthcare Safety Network case definition for laboratory-identified CRE events were submitted to WSLH. On June 8, 2015, WSLH notified WDPH that five carbapenemase-producing CRE isolates with closely related PFGE patterns had been identified among four inpatients at two hospitals in southeastern Wisconsin. A subsequent investigation included analysis of routine PFGE subtyping to detect clusters among all carbapenemase-producing CRE isolates submitted to WSLH and identify possible transmission events not recognized by hospital personnel. WSLH performed WGS on the five-cluster KPC-CRE isolates to characterize further the genetic relatedness. Interpretation of WGS was done at the CDC using Lyve-SET, analysis software that identifies high quality SNPs (hqSNPs; sites with at least 10X coverage and 75% consensus). The bootstrap statistical method (resampling with replacement) was used to assess phylogenetic variation among genes in the WGS.

 

To determine hospital care points common to the four patients and possible modes of CRE transmission, WDPH personnel developed an instrument for epidemiologic data collection and conducted medical record reviews, site visits (October 28 and November 9, 2015), a review of respiratory care protocols, and interviews with infection prevention staff members, primary care providers, and patients (when available). During July 15–August 12, 2015, active surveillance was conducted in the respiratory units of concern at the two hospitals to determine whether ongoing transmission of KPC-CRE was occurring. Surveillance rectal swabs were collected once weekly among all patients hospitalized in the two respiratory units and submitted to WSLH for CRE culture.

 

Among the 49 isolates submitted during February–May 2015, one cluster of five KPC-CRE isolates with two closely related PFGE patterns was detected among four inpatients (patients A–D) at two hospitals (hospital 1 and hospital 2) in southeastern Wisconsin: one isolate each from patients A, B, and D, and two isolates from patient C. The remaining 44 isolates, which included 20 KPC-CRE isolates, had unique PFGE patterns that did not match one another or the cluster patterns.

 

Isolates obtained from patients A and B (hospital 1) differed by two hqSNPs; no hqSNP differences were detected among isolates from patients C and D (hospital 2). Isolates from patients A and B each differed from isolates from patients C and D by only one hqSNP, indicating a high degree of sequence relatedness among all five KPC-CRE isolates. This is consistent with the occurrence of one or more intrafacility transmission events in hospital 1 and hospital 2.

 

Median age of the four patients was 65 years (range = 52–75 years), all were non-Hispanic whites, and two were women; median hospitalization length was 83 days (range = 65–103 days). Illnesses diagnosed among the patients at admission included postviral ascending weakness consistent with Guillain-Barré syndrome, cerebrovascular accident, pneumonia, and bacteremia during and after chemotherapy, radiation, and surgical resection of a glioblastoma. All four patients had been intubated and undergone a tracheostomy and had previous percutaneous endoscopic gastrostomy performed. However, none of these procedures had occurred at the same facility. None of the patients had undergone a gastrointestinal procedure that placed them at high risk for exposure to CRE (e.g., endoscopic retrograde cholangiopancreatography).

 

Patient A was hospitalized during December 11, 2014,–January 22, 2015, and patient B was hospitalized during March 20–April 26, 2015, in the same respiratory unit of hospital 1, but 57 days apart. Patient C was hospitalized during March 2–May 8, 2015, in hospital 2’s medical respiratory intensive care unit, and patient D was hospitalized during February 26–April 6, 2015, on the orthopedic surgical floor and was subsequently hospitalized in the medical respiratory intensive care unit during June 2–June 16, 2015, 25 days after patient C was discharged. On March 22, 2015, patients C and D had a 24-hour period of overlap in hospital 2’s medical respiratory intensive care unit, when patient D was moved from the orthopedic surgical floor for acute respiratory management. Although patients A–D were not transferred between hospitals 1 and 2, patient transfers between these two facilities are common.

 

A total of 122 rectal swabs were collected among 83 patients hospitalized in the two respiratory units during July 15–August 12 (the active surveillance period). During this period, a patient with previously known KPC-CRE infection (Patient E) was transferred from hospital 2 to hospital 1. Other than a specimen isolate from patient E, which did not match the cluster isolates, no KPC-CRE isolates were recovered in culture and no evidence of further CRE transmission was detected.

 

WDPH personnel conducted site visits and reviewed infection prevention protocols and policies for care of the ventilator circuit with infection prevention personnel at both facilities. These reviews were based on the CDC Guidelines for Preventing Health-Care–Associated Pneumonia. No breaches in recommended practices were identified; however, infection prevention personnel could not describe respiratory personnel hand hygiene practices after handling of the circuit tubing. Thus, WDPH personnel recommended a facility compliance check of those practices. Public health actions to prevent future transmission of CRE at these hospitals included WDPH personnel working with infection prevention staff members regarding infection prevention measures related to ventilator care. No subsequent clusters of KPC-CREs have been reported from hospitals 1 and 2.

 

Although the precise mechanism of CRE transmission was not determined, WDPH personnel used the detection of the KPC-CRE cluster to raise awareness among the hospitals’ infection prevention staff members regarding the possibility of intrafacility CRE transmission events among their patients. The circumstances provided an opportunity for review of facility infection prevention practices and respiratory care processes critical to prevention of health care–associated pneumonia. After addressing these concerns, no evidence of further transmission of these closely related strains of KPC-CRE at these facilities was found.

 

The investigation demonstrated the importance of routine hospital- and laboratory-based surveillance for the detection of health care–related transmission of CRE. The use of molecular subtyping methods (e.g., PFGE and WGS) to determine genetic relatedness of the bacterial isolates was particularly valuable. Matching PFGE patterns among isolates and subsequent WGS analysis of KPC-CRE led to focused epidemiologic investigations, subsequent cluster identification, and opportunities to provide infection prevention education to staff members at the involved hospitals.

 

Although routine use of PFGE and subsequent WGS in this investigation represents a novel application of technology to detect CRE transmission, the burden of resources might preclude similar use in states with medium-to-high prevalences of CRE. However, the increasing availability of WGS might improve utility of this approach in the future. In Wisconsin, a state with relatively low CRE prevalence since the inception of statewide CRE surveillance during December 2011–April 2016, PFGE has been conducted on 225 CRE isolates (average = ~50 per year). Five clusters have been detected, and attendant public health–related responses likely prevented further transmission and case occurrences in health care facilities.

 

This report is subject to at least one limitation. PFGE patterns can be remarkably similar among certain CRE in the absence of any epidemiologic link. This is especially true of ST258 CR-producing Klebsiella pneumoniae. Therefore, PFGE data must be considered with epidemiologic data to determine potential transmission events.

 

Multidrug-resistant organisms, in particular CRE, have the capability of spreading undetected, with the possibility of devastating outbreaks in health care settings. Routine hospital- and laboratory-based surveillance for the detection of CRE and the use of molecular techniques to characterize isolates can detect and reduce occurrence of multidrug-resistant infections through interventions designed to interrupt transmission. Timely access to technology and results can facilitate rapid implementation of effective interventions.

 

See the CDC Report

 

See also Medical Law Perspectives, June 2016 Report: How Risky Is Going to the Hospital? The Dangers and Liabilities of Healthcare-Associated Infections 

 

 

REPRINTS & PERMISSIONS COMMENT